• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22189 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     NIHR Health Services and Delivery Research programme Evidence for models of diagnostic service provision in the community: literature mapping exercise and focused rapid reviews
2016     Institute of Health Economics (IHE) Oxygen therapy in acute care settings
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and decision aid for bowel cancer screening]
2016     HAYES, Inc. Noninvasive electrical bone growth stimulators for acute, delayed union, and nonunion fractures
2016     NIHR Health Services and Delivery Research programme DO NOT INDEX The Men's Safer Sex project: intervention development and feasibility randomised controlled trial of an interactive digital intervention to increase condom use in men
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Carfilzomib (multiple myeloma; combination with dexamethasone alone) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016     HAYES, Inc. Optical Coherence Tomography (OCT) for plaque characterization and stent implantation
2016     Penn Medicine Center for Evidence-based Practice (CEP) Adverse events in oncology patients with reduced platelet counts and oncurrent anemia
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pitolisant (narcolepsy) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016     HAYES, Inc. Panniculectomy for treatment of symptomatic panniculi
2016     Penn Medicine Center for Evidence-based Practice (CEP) Social work support following distress screening in oncology care
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tasimelteon (non-24-hour sleep-wake disorder in totally blind adults) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016     Agency for Healthcare Research and Quality (AHRQ) Diagnosis of celiac disease
2016     HAYES, Inc. Percutaneous mechanical thrombectomy for deep vein thrombosis
2016     NIHR Health Technology Assessment programme The Men's Safer Sex project: intervention development and feasibility randomised controlled trial of an interactive digital intervention to increase condom use in men
2016     Penn Medicine Center for Evidence-based Practice (CEP) Oncology nurse navigators
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brentuximab vedotin (Hodgkin lymphoma with an increased risk of relapse or progression) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Bariatric surgery for diabetes mellitus type 2 control in adults with BMI<35 kg/m2
2016     Agency for Healthcare Research and Quality (AHRQ) Improving antibiotic prescribing for uncomplicated acute respiratory tract infections
2016     HAYES, Inc. Percutaneous mechanical thrombectomy for pulmonary embolism
2016     Penn Medicine Center for Evidence-based Practice (CEP) Patient transfer from the postanesthesia care unit to an inpatient medical surgical unit
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teduglutide (short bowel syndrome; patients from the age of 1 year) - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Hand transplantation following amputation due to non-malignant indications
2016     Haute Autorite de sante (HAS) [Evaluation of gene amplification for diagnosis Herpesviridae infections (cytomegalovirus, herpes simplex virus and varicella-zoster) in people living with HIV]
2016     HAYES, Inc. Proton beam therapy for prostate cancer
2016     Penn Medicine Center for Evidence-based Practice (CEP) Elective cesarean section surgery and maternal music listening
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Surgical treatment of gallbladder cancer
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke. National Report: German Summary of the correspondent EUnetHTA Report]
2016     Agency for Healthcare Research and Quality (AHRQ) Medication-assisted treatment models of care for opioid use disorder in primary care settings
2016     Penn Medicine Center for Evidence-based Practice (CEP) Amiodarone method of administration for treatment of post-operative atrial fibrillation
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elotuzumab (multiple myeloma) - Addendum to Commission A16-32]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Positron emission tomography and computed tomographic imaging prior to radiotherapy for lung cancer
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) in addition to standard chemotherapy for the first-line treatment of ovarian cancer
2016     Agency for Healthcare Research and Quality (AHRQ) Strategies for improving the lives of women aged 40 and above living with HIV/AIDS.
2016     Penn Medicine Center for Evidence-based Practice (CEP) Pathways for management of refractory epistaxis
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Positron emission tomography and computed tomographic imaging prior to radiotherapy for anal cancer
2016     NIHR Health Technology Assessment programme Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in women with suspicious pelvic masses
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) who are refractory to erlotinib/gefitinib and afatinib monotherapy
2016     Penn Medicine Center for Evidence-based Practice (CEP) Transfusion thresholds in cardiovascular surgery
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Eribulin (liposarcoma) - Addendum A16-31
2016     The Regional Health Technology Assessment Centre (HTA-centrum) Does salpingectomy reduce the risk of ovarian cancer?
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Drugs in oncology: an overview of benefit and refund practices in Europe]
2016     Penn Medicine Center for Evidence-based Practice (CEP) Erythropoiesis stimulating agents for cardiac surgery patients
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Health Technology Assessment programme Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
2016     Penn Medicine Center for Evidence-based Practice (CEP) Clinical risk prediction scales for venous thromboembolism in hospitalized patients
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Measurement of myocardial fractional flow reserve (FFR) in coronary heart disease]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016]
2016     Penn Medicine Center for Evidence-based Practice (CEP) Managing antenatal hypoglycemia in hospitalized pregnant women with diabetes
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for severe combined immunodeficiency (SCID screening)]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Oxecam for health monitoring in secure mental health facilities
2016     NIHR Health Services and Delivery Research programme The INCENTIVE study: a mixed-methods evaluation of an innovation in commissioning and delivery of primary dental care compared with traditional dental contracting
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorders]
2016     Penn Medicine Center for Evidence-based Practice (CEP) Duration of contact isolation precautions for patients with a history of MRSA infection or colonization
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin + saxagliptin/metformin: Addendum to Commission A16-42 + A16-43]
2016     Haute Autorite de sante (HAS) [Endovascular thrombectomy of intracranial arteries]
2016     NIHR Health Technology Assessment programme Cognitive-behavioural therapy-based intervention to reduce fear of falling in older people: therapy development and randomised controlled trial - the Strategies for Increasing Independence, Confidence and Energy (STRIDE) study
2016     NIHR Health Technology Assessment programme The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
2016     NIHR Horizon Scanning Centre (NIHR HSC) Neon EEG for monitoring neonatal seizures
2016     NIHR Health Services and Delivery Research programme Infant deaths in the UK community following successful cardiac surgery: building the evidence base for optimal surveillance, a mixed-methods study
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Leadless pacemakers for right ventricle pacing
2016     Penn Medicine Center for Evidence-based Practice (CEP) Duration of contact isolation precautions for patients with a history of MRSA infection or colonization
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (melanoma): Addendum to Commission A16-35]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2016     NIHR Health Technology Assessment programme Evaluating Acupuncture and Standard care for pregnant womEn with BACK pain (EASE BACK): a feasibility and pilot study
2016     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Selection of health priorities: criteria, process and strategic framework. Systematic review]
2016     NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2016     NIHR Public Health Research (PHR) programme Bristol Girls Dance Project: a cluster randomised controlled trial of an after-school dance programme to increase physical activity among 11- to 12-year-old girls
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single-step scaffold-based cartilage repair in the knee
2016     Penn Medicine Center for Evidence-based Practice (CEP) Bedside psychotherapy for depression or anxiety in hospitalized medical-surgical patients
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Measurement of preference in parodontopathy]
2016     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Guideline for the elaboration and adaptation of rapid health technology assessment reports]
2016     NIHR Horizon Scanning Centre (NIHR HSC) AVATAR therapy for auditory verbal hallucinations in psychosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Blinatumomab (Blincyto) for relapsed or refractory Philadelphia-positive B-precursor acute lymphoblastic leukaemia – second or subsequent line
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for sacroiliac and facet joint pain
2016     Norwegian Institute of Public Health (NIPH) Medicines used for multiple sclerosis. A health technology assessment
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia): Addendum to Commission A16-39]
2016     Agency for Healthcare Research and Quality (AHRQ) Total Worker Health®
2016     NIHR Horizon Scanning Centre (NIHR HSC) myPlan™ test for early-stage lung adenocarcinoma prognosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Avelumab for Merkel cell carcinoma – second line
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper airway stimulation for moderate-to-severe sleep apnea
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir/velpatasvir (chronic hepatitis C) - Addendum to Commission A16-48]
2016     NIHR Health Technology Assessment programme PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term a cluster randomised controlled trial and economic evaluation
2016     NIHR Public Health Research (PHR) programme Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions
2016     NIHR Horizon Scanning Centre (NIHR HSC) Methoxyflurane (Penthrox) for emergency relief of moderate to severe pain
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
2016     NIHR Horizon Scanning Centre (NIHR HSC) CPX-351 (VYXEOS) for elderly patients with newly diagnosed acute myeloid leukaemia – first line
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Obinutuzumab (Gazyvaro®) in combination with bendamustine for the treatment of relapsed/refractory follicular lymphoma (FL)
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Opicapone (Parkinson disease) - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Carfilzomib (Kyprolis) in combination with dexamethasone for relapsed multiple myeloma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) ATIR101 for patients with haematological malignancy who are candidates for haematopoietic stem cell transplantation – adjunctive therapy
2016     Norwegian Institute of Public Health (NIPH) Health technology assessment of four drugs for patients with metastatic castration resistant prostate cancer
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ceritinib (lung cancer): benefit assessment according to §35a Social Code Book V; expiry of the decision
2016     NIHR Horizon Scanning Centre (NIHR HSC) Buparlisib with fulvestrant for postmenopausal women with metastatic oestrogen-receptor positive, HER2 negative breast cancer – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Carfilzomib (Kyprolis) in combination with melphalan and prednisone for multiple myeloma – first line
2016     NIHR Health Technology Assessment programme Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer [ID915]
2016     Norwegian Institute of Public Health (NIPH) [Non-invasive prenatal testing (NIPT) for foetal sex determination]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Crizotinib (lung cancer) - Benefit assessment according to §35a Social Code Book V]